drugset / Trial / NCT00257361

D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder

NCT00257361 ↗

RandomizedSingle-groupOpen-label

Summary

We propose to undertake an initial study of DCS to determine whether it has any short-term clinical benefits when added to standard ERP therapy in adults with OCD.

Timeline

Start
2005-07
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “PI left the university”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule — —